دورية أكاديمية

Improved emptying performance with a new micro-hole zone catheter in adult male intermittent catheter users: A comparative multi-center randomized controlled cross-over study.

التفاصيل البيبلوغرافية
العنوان: Improved emptying performance with a new micro-hole zone catheter in adult male intermittent catheter users: A comparative multi-center randomized controlled cross-over study.
المؤلفون: Thiruchelvam N; Department of Urology, NHS Foundation Trust, Addenbrooke's Hospital, Cambridge University Hospital, Cambridge, UK., Landauro MH; Coloplast A/S, Humlebaek, Denmark., Biardeau X; Centre Hospitalier Universitaire de Lille, Lille Cedex, France., Rovsing C; Sanos Clinic, Gandrup, Denmark., Hahn M; ARTIMED Medical Consulting GmbH, Kassel, Germany., Nascimento OFD; Coloplast A/S, Humlebaek, Denmark., Gardner S; Hazelwood House, Macclesfield, UK., Amarenco G; Department of Neuro-Urology, Tenon Hospital, Paris, France., Bagi P; Department of Urology, Rigshospitalet, København Ø, Denmark.
المصدر: Neurourology and urodynamics [Neurourol Urodyn] 2024 Feb; Vol. 43 (2), pp. 464-478. Date of Electronic Publication: 2024 Jan 09.
نوع المنشور: Randomized Controlled Trial; Multicenter Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6777 (Electronic) Linking ISSN: 07332467 NLM ISO Abbreviation: Neurourol Urodyn Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York : Alan R. Liss, c1982-
مواضيع طبية MeSH: Urinary Tract Infections* , Intermittent Urethral Catheterization*/methods , Urinary Bladder, Neurogenic*/etiology , Urinary Bladder, Neurogenic*/therapy, Adult ; Humans ; Male ; Cross-Over Studies ; Hematuria ; Urinary Catheters ; Urinary Catheterization/methods
مستخلص: Aims: To confirm the improved performance of the micro-hole zone catheter (MHZC) compared to a conventional eyelet catheter (CEC) in male users of clean intermittent catheterizations (CICs).
Methods: Male self-catheterizing subjects, who used hydrophilic sleeved soft/flexible CIC as the only bladder emptying method, were enrolled into a multi-center, randomized, cross-over study performed across six European sites. Subjects tested the MHZC, featuring a drainage zone with 120 micro-holes and a CEC with two eyelets. The study consisted of four study visits (V0-V3), during which endpoints related to catheter performance (urinary flow-stops, bladder emptying, and intra-catheter pressure) were measured and two 4-week test periods at home (T1 and T2) where dipstick hematuria and user perception between catheters were evaluated.
Results: Seventy-three male subjects with non-neurogenic and neurogenic bladder dysfunction (3:2) were enrolled. On average, catheterizations with the MHZC led to close to mean zero flow-stops compared to ≥1 flow-stops with the CEC, during both HCP- and self-led catheterizations (both p < 0.001). Residual urine at first flow-stop was significantly reduced for the MHZC compared to CEC (p = 0.001 and p = 0.004, for HCP- and self-led catheterizations, respectively). This was substantiated by a significantly smaller pressure peak at first flow-stop, a proxy for minimized mucosal suction (both HCP- and self-led catheterizations, p < 0.001). After home-use catheterizations, dipstick hematuria was comparable between catheters, whereas catheterizations were associated with significantly improved perception in favor of MHZC regarding bladder emptying, less blocking sensation, and improved hygienic catheterization compared to the CEC.
Conclusion: This study confirmed the evidence of improved bladder emptying with the MHZC compared to a CEC without the need to reposition the catheter. The MHZC therefore offers an enhanced benefit for the dependent CIC user securing complete bladder emptying in an uninterrupted free flow and reducing the need to reposition the catheter during emptying.
(© 2024 Coloplast A/S. Neurourology and Urodynamics published by Wiley Periodicals LLC.)
References: Flores-Mireles A, Hreha TN, Hunstad DA. Pathophysiology, treatment, and prevention of catheter-associated urinary tract infection. Top Spinal Cord Inj Rehabil. 2019;25(3):228-240. doi:10.1310/sci2503-228.
Öztürk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669-2679. doi:10.1007/s00345-019-03071-4.
Welk B, Lenherr S, Santiago-Lastra Y, Norman HS, Keiser MG, Elliott CS. Differences in the incidence of urinary tract infections between neurogenic and non-neurogenic bladder dysfunction individuals performing intermittent catheterization. Neurourol Urodyn. 2022;41(4):1002-1011. doi:10.1002/nau.24914.
Anderson CE, Chamberlain JD, Jordan X, et al. Bladder emptying method is the primary determinant of urinary tract infections in patients with spinal cord injury: results from a prospective rehabilitation cohort study. BJU Int. 2019;123(2):342-352. doi:10.1111/bju.14514.
Kennelly M, Thiruchelvam N, Averbeck MA, et al. Adult neurogenic lower urinary tract dysfunction and intermittent catheterisation in a community setting: risk factors model for urinary tract infections. Adv Urol. 2019;2019:1-13. doi:10.1155/2019/2757862.
Kinnear N, Barnett D, O'Callaghan M, Horsell K, Gani J, Hennessey D. The impact of catheter-based bladder drainage method on urinary tract infection risk in spinal cord injury and neurogenic bladder: a systematic review. Neurourol Urodyn. 2020;39(2):854-862. doi:10.1002/nau.24253.
Dinh A, Davido B, Duran C, et al. Urinary tract infections in patients with neurogenic bladder. Med Mal Infect. 2019;49(7):495-504. doi:10.1016/j.medmal.2019.02.006.
Shekelle PG, Morton SC, Clark KA, Pathak M, Vickrey BG. Systematic review of risk factors for urinary tract infection in adults with spinal cord dysfunction. J Spinal Cord Med. 1999;22(4):258-272. doi:10.1080/10790268.1999.11719579.
Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn. 2014;33(1):95-100. doi:10.1002/nau.22378.
Wyndaele JJ, Brauner A, Geerlings SE, Bela K, Peter T, Bjerklund-Johanson TE. Clean intermittent catheterization and urinary tract infection: review and guide for future research. BJU Int. 2012;110(11 Pt C):910-917. doi:10.1111/j.1464-410X.2012.11549.x.
Milles G. Catheter-induced hemorrhagic pseudopolyps of the urinary bladder. JAMA. 1965;193:968-969. doi:10.1001/jama.1965.03090110106036.
Isaacs JH, McWhorter DM. Foley catheter drainage systems and bladder damage. Surg Gynecol Obstet. 1971;132(5):889-891.
Glahn BE. Influence of drainage conditions on mucosal bladder damage by indwelling catheters. I. Pressure study. Scand J Urol Nephrol. 1988;22(2):87-92. doi:10.1080/00365599.1988.11690391.
Glahn BE, Braendstrup O, Olesen HP. Influence of drainage conditions on mucosal bladder damage by indwelling catheters: II. Histological study. Scand J Urol Nephrol. 1988;22(2):93-99. doi:10.1080/00365599.1988.11690392.
Grocela JA, Jura YH. Top-vented urinary drainage catheters cause fewer epithelial and vascular changes in the bladder mucosa compared to conventional catheters and may reduce susceptibility to urinary tract infections. Curr Urol. 2010;4(3):136-141. doi:10.1159/000253440.
Tentor F, Grønholt Schrøder B, Nielsen S, et al. Development of an ex-vivo porcine lower urinary tract model to evaluate the performance of urinary catheters. Sci Rep. 2022;12(1):17818. doi:10.1038/s41598-022-21122-6.
Landauro MH, Jacobsen L, Tentor F, et al. New intermittent urinary micro-hole zone catheter shows enhanced performance in emptying the bladder: a randomised, controlled crossover study. J Clin Med. 2023;12(16):5266. doi:10.3390/jcm12165266.
Exploratory Investigation on Performance and Safety of New Intermittent Catheters in Healthy Volunteers. Accessed June 7, 2023. https://clinicaltrials.gov/ct2/show/NCT04445051.
Exploratory Investigation on Performance and Safety of Newly Developed Intermittent Catheters in Male Users of Intermittent Catheters. Accessed June 2023. https://clinicaltrials.gov/ct2/show/NCT04543136.
A Randomized, Open-Labelled, Crossover Study Confirming the Performance of A Single-use Intermittent Micro-Hole Zone Catheter in A Population of Adult Male Intermittent Catheter Users. Accessed June 7, 2023. https://clinicaltrials.gov/ct2/show/NCT05485922.
De Ridder DJMK, Everaert K, Fernández LG, et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial. Eur Urol. 2005;48(6):991-995. doi:10.1016/j.eururo.2005.07.018.
Coloplast A/S. SpeediCath®Standard, Instructions for Use. https://s28647.pcdn.co/wp-content/uploads/2018/10/Coloplast-SpeediCath-Instructions-for-Use.pdf.
Hollister. VaPro coudé, Intermittent Catheter, Guide for Use. https://www.hollister.com/-/media/files/pdfs-for-download/continence-care/vapro-coude-catheters-guide-for-use.ashx.
Vahr S, Cobussen-Boekhorst H, Eikenboom J, et al. Evidence-based guidelines for best practice in urological health care catheterisation: urethral intermittent in adult. European Association of Urology Nurses. 2020. https://nurses.uroweb.org/guideline/catheterisation-urethral-intermittent-in-adults/.
Wellspect Healthcare. Instructions for Preparing the LoFric Catheter for Use. https://medicalmonks.com/wp-content/uploads/2014/12/LoFric-Instruction-Sheet.pdf.
Jensen AE, Hjeltnes N, Berstad J, Stanghelle JK. Residual urine following intermittent catheterisation in patients with spinal cord injuries. Paraplegia. 1995;33(12):693-696. doi:10.1038/sc.1995.145.
Caron F, Alexandre K, Pestel-Caron M, Chassagne P, Grise P, Etienne M. High bacterial titers in urine are predictive of abnormal postvoid residual urine in patients with urinary tract infection. Diagn Microbiol Infect Dis. 2015;83(1):63-67.
Chen C-M, Hsu H-C, Tsai W-S, Chang C-H, Chen K-H, Hong C-Z. Infections in acute older stroke inpatients undergoing rehabilitation. Am J Phys Med Rehabil. 2012;91(3):211-219.
Dromerick AW, Edwards DF. Relation of postvoid residual to urinary tract infection during stroke rehabilitation. Arch Phys Med Rehabil. 2003;84(9):1369-1372.
Kim B-R, Lim JH, Lee SA, et al. The relation between postvoid residual and occurrence of urinary tract infection after stroke in rehabilitation unit. Ann Rehabil Med. 2012;36(2):248.
May M, Brookman-Amissah S, Hoschke B, Gilfrich C, Braun K-P, Kendel F. Post-void residual urine as a predictor of urinary tract infection-is there a cutoff value in asymptomatic men? J Urol. 2009;181(6):2540-2544.
Stern JA, Hsieh Y-C, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol. 2004;171(2):768-770.
Truzzi JCI, Almeida FMR, Nunes EC, Sadi MV. Residual urinary volume and urinary tract infection-when are they linked? J Urol. 2008;180(1):182-185.
Tornic J, Wöllner J, Leitner L, Mehnert U, Bachmann LM, Kessler TM. The challenge of asymptomatic bacteriuria and symptomatic urinary tract infections in patients with neurogenic lower urinary tract dysfunction. J Urol. 2020;203(3):579-584. doi:10.1097/ju.0000000000000555.
Anderson RU. Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol. 1980;123(3):364-366. doi:10.1016/s0022-5347(17)55938-8.
Merritt JL. Residual urine volume: correlate of urinary tract infection in patients with spinal cord injury. Arch Phys Med Rehabil. 1981;62(11):558-561.
Bragadin MM, Motta R, Uccelli MM, et al. Lower urinary tract dysfunction in patients with multiple sclerosis: a post-void residual analysis of 501 cases. Mult Scler Relat Disord. 2020;45:102378. doi:10.1016/j.msard.2020.102378.
Vasdev N, Kumar A, Veeratterapillay R, Thorpe AC. Hematuria secondary to benign prostatic hyperplasia: retrospective analysis of 166 men identified in a single one stop hematuria clinic. Curr Urol. 2013;6(3):146-149. doi:10.1159/000343529.
Domurath B, Kutzenberger J, Kurze I, Knoth HS. Clinical evaluation of a newly developed catheter (SpeediCath Compact Male) in men with spinal cord injury: residual urine and user evaluation. Spinal Cord. 2011;49(7):817-821. doi:10.1038/sc.2011.14.
Kessler TM, Ryu G, Burkhard FC. Clean intermittent self-catheterization: a burden for the patient? Neurourol Urodyn. 2009;28(1):18-21. doi:10.1002/nau.20610.
Litherland AT, Schiøtz HA. Patient-perceived discomfort with two coated urinary catheters. Br J Nurs. 2007;16(5):284-287. doi:10.12968/bjon.2007.16.5.23000.
McClurg D, Bugge C, Elders A, et al. Factors affecting continuation of clean intermittent catheterisation in people with multiple sclerosis: results of the COSMOS mixed-methods study. Mult Scler J. 2019;25(5):727-739. doi:10.1177/1352458518768722.
Koeter I, Stensröd G, Hunsbedt Nilsen A, et al. User perception of a new hydrophilic-coated male urinary catheter for intermittent use. Nurs Open. 2019;6(1):116-125. doi:10.1002/nop2.193.
Pinder B, Lloyd AJ, Nafees B, Elkin EP, Marley J. Patient preferences and willingness to pay for innovations in intermittent self-catheters. Patient Prefer Adherence. 2015;9:381-388. doi:10.2147/ppa.S73487.
Islamoska MHL S, Zeeberg R, Jacobsen L, Vaabengaard R. Patient-Reported Risk Factors for Urinary Tract Infections are Associated with Lower Quality of Life and Higher Risk of Urinary Tract Infection among Users of Clean Intermittent Catherization [Abstract]. 2022.
Roth JD, Pariser JJ, Stoffel JT, et al. Patient subjective assessment of urinary tract infection frequency and severity is associated with bladder management method in spinal cord injury. Spinal Cord. 2019;57(8):700-707. doi:10.1038/s41393-019-0268-2.
Bolinger R, Engberg S. Barriers, complications, adherence, and self-reported quality of life for people using clean intermittent catheterization. J Wound Ostomy Continence Nurs. 2013;40(1):83-89. doi:10.1097/WON.0b013e3182750117.
فهرسة مساهمة: Keywords: clean intermittent catheterization; micro-hole drainage zone; urinary bladder disease; urinary flow-stop; urinary retention; urinary tract infection
تواريخ الأحداث: Date Created: 20240110 Date Completed: 20240206 Latest Revision: 20240206
رمز التحديث: 20240206
DOI: 10.1002/nau.25383
PMID: 38196237
قاعدة البيانات: MEDLINE
الوصف
تدمد:1520-6777
DOI:10.1002/nau.25383